{
    "organizations": [],
    "uuid": "734aac5967adbafe82f97fdd0f507d615a9a01fd",
    "author": "",
    "url": "https://www.reuters.com/article/brief-menlo-therapeutics-says-japanese-p/brief-menlo-therapeutics-says-japanese-phase-2-trial-of-serlopitant-halted-idUSFWN1S11BT",
    "ord_in_thread": 0,
    "title": "BRIEF-Menlo Therapeutics Says Japanese Phase 2 Trial Of Serlopitant Halted",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Menlo Therapeutics Inc:\n* MENLO THERAPEUTICS - COâ€™S PARTNERS FOR COMMERCIALIZATION OF SERLOPITANT IN JAPAN, INFORMED DECISION TO HALT JAPANESE PHASE 2 CLINICAL TRIAL OF SERLOPITANT\n* MENLO SAYS JT TORII HAS INDICATED THEY ARE REEVALUATING THEIR SERLOPITANT DEVELOPMENT PROGRAM BASED UPON EVOLVING COMMERCIAL CONSIDERATIONS IN JAPAN\n* MENLO THERAPEUTICS INC - BASED UPON COMMUNICATION WITH JT TORII, CO EXPECTS JT TORII LICENSE AGREEMENT FOR SERLOPITANT WILL ULTIMATELY BE TERMINATED Source text ( bit.ly/2qZpi4G ) Further company coverage:\n ",
    "published": "2018-04-24T23:31:00.000+03:00",
    "crawled": "2018-04-25T01:26:12.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "menlo",
        "therapeutic",
        "inc",
        "menlo",
        "therapeutic",
        "co",
        "partner",
        "commercialization",
        "serlopitant",
        "japan",
        "informed",
        "decision",
        "halt",
        "japanese",
        "phase",
        "clinical",
        "trial",
        "serlopitant",
        "menlo",
        "say",
        "jt",
        "torii",
        "indicated",
        "reevaluating",
        "serlopitant",
        "development",
        "program",
        "based",
        "upon",
        "evolving",
        "commercial",
        "consideration",
        "japan",
        "menlo",
        "therapeutic",
        "inc",
        "based",
        "upon",
        "communication",
        "jt",
        "torii",
        "co",
        "expects",
        "jt",
        "torii",
        "license",
        "agreement",
        "serlopitant",
        "ultimately",
        "terminated",
        "source",
        "text",
        "company",
        "coverage"
    ]
}